8GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
9Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
10Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
2Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD[J]. Chest,2011,139(1) :165-173.
3Dima E, Rovina N, Gerassimou C, et al. Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic toolsin the challenge of distinguishing asthma and COPD phenotypes in clinical practice[J]. Int J Chron Obstruct Pulmon Dis,2010,7(5) :287-296.
